Astellas Receives Permanent J-code for IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy

Permanent J-code J2782 effective April 1, 2024
NORTHBROOK, Ill., March 26, 2024 /PRNewswire/ -- Iveric Bio, An Astellas Company , today announced the U.S. Centers for Medicare and Medicaid Services...

Related Keywords

Naoki Okamura ,Michael Petroutsas ,Iveric Bio ,Medicaid Services ,Astellas Pharma Inc ,Astellas Company ,Astellas Pharma Us Inc ,Us Centers For Medicare ,Healthcare Common Procedure Coding System ,Focus Area Approach ,Markets ,